AdvanCell

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Jul 15, 2026	Series D	$315M	Abingworth — Role not disclosedAlly Bridge Group — Role not disclosedAlpha Wave — Role not disclosedBain Capital Life Sciences — Role not disclosedBrandon Capital — Role not disclosedCatalio Capital Management — Role not disclosedEli Lilly and Company — Role not disclosedEventide Asset Management — Role not disclosedFidelity Management & Research Company — Role not disclosedMorningside — Role not disclosedPiper Heartland — Role not disclosedProto Axiom — Role not disclosedSanofi Ventures — Role not disclosedSV Health Investors — Role not disclosedSymBiosis — Role not disclosedTenmile — Role not disclosedTime BioVentures — Role not disclosed

Sources